LB Pharmaceuticals

tenant

drug

Mindfulness Resiliency Training

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

BEHAVIORAL

Pre-approval / investigational in the US

Developed by Yale University

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

BEHAVIORAL

Indications

Investigational (via trials)

Substance-Related Disorders Depression War-Related Trauma War-Related Injuries Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)Psychotic Disorders Personality Disorders Mental Health Wellness 1

Trials

1

Evaluation of A Mindfulness Resiliency Training Program for Refugees Living in Jordan

NCT03760627—Completed

KOLs & investigators

2

Saquib Lakhani, MD

Prachi Syngal, MD

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

Yale University

company

trial

Evaluation of A Mindfulness Resiliency Training Program for Refugees Living in Jordan

NA

trial

indication

Substance-Related Disorders

indication

indication

War-Related Trauma

indication

War-Related Injuries

indication

KOL

Saquib Lakhani, MD

KOL score —

person

Prachi Syngal, MD

KOL score —

person